The Galleri test aims to find fragments of DNA in a person’s blood that can indicate the presence of a cancerous tumor.
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced landmark results demonstrating ...
Without an easy way to screen and with nondescript symptoms, ovarian cancer is often caught in late stages, requiring massive ...
The Galleri test - dubbed the 'holy grail' for cancer - screens for more than 50 cancers, often picking up signs before ...
Trials of the Galleri test that screens for more than 50 cancers showed it was correct in 62% of cases where it thought ...